Celcuity CELC
Nasdaq · Services-Medical Laboratories$56.31+1.28%Nov 19 close · Databento
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
On the Wire
what CELC did at the next close after each storyAug 26
Celcuity submits FDA application for REVTORPYK in PIK3CA-mutant breast cancer
+3.05%GlobeNewswire · 8:30 AM ET
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.